LMR Partners LLP Takes Position in iShares Biotechnology ETF (NASDAQ:IBB)

LMR Partners LLP bought a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 33,678 shares of the financial services provider’s stock, valued at approximately $4,904,000. LMR Partners LLP owned approximately 0.07% of iShares Biotechnology ETF at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Highline Wealth Partners LLC acquired a new position in iShares Biotechnology ETF during the 3rd quarter worth approximately $30,000. Bbjs Financial Advisors LLC acquired a new position in iShares Biotechnology ETF during the 2nd quarter worth approximately $31,000. Ashton Thomas Securities LLC acquired a new position in iShares Biotechnology ETF during the 3rd quarter worth approximately $36,000. Voisard Asset Management Group Inc. acquired a new position in iShares Biotechnology ETF during the 3rd quarter worth approximately $59,000. Finally, Aptus Capital Advisors LLC increased its position in iShares Biotechnology ETF by 36.5% during the 3rd quarter. Aptus Capital Advisors LLC now owns 426 shares of the financial services provider’s stock worth $62,000 after purchasing an additional 114 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ IBB opened at $133.04 on Tuesday. iShares Biotechnology ETF has a 52-week low of $117.28 and a 52-week high of $150.57. The firm has a 50 day moving average price of $144.26 and a two-hundred day moving average price of $141.80.

iShares Biotechnology ETF Announces Dividend

The company also recently disclosed a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.